With Parkinson’s disease

Some information here…

, it’s all about time.

Time has stood still. Despite many therapeutic options, there are still no restorative or disease-modifying treatments.
Time is of the essence for patients as the disease progresses.
We’re answering the call… It’s time to turn back the clock on Parkinson’s

Here’s How

Our personalized Autologous Cell Therapy is

  • Powered by our leading-edge manufacturing platform to treat Parkinson’s patients with an investigational one-time therapy.
  • Aiming to restore motor function and quality of life, with the potential to stimulate dopamine production & rebuild the neural networks.

From cell reprogramming to patient delivery, we integrate science, genomics, AI, and manufacturing under one roof — with one mission… to transform patient care.

Well-established, Precise Delivery


Stringent Quality Control at Each Stage

Your Cells, Your Therapy

  1. Fibroblasts

    Skin cells isolated from a small skin punch biopsy. Fibroblasts are the starting material for creating our personalized therapy.

  2. Induced Pluripotent Stem Cells (iPSCs)

    Fibroblasts are reprogrammed into iPSCs, turning back the cell’s biological clock to a pre-diseased state. These stem cells can develop into different cell types.

  3. Dopaminergic Neuron Precursor cells (DANPCs)

    iPSCs are differentiated into DANPCs, precursor cells that can mature into dopamine-producing neurons.